Explore evidence

40.4 %453 (40.4%) of the 1120 patients had a baseline CD4 count of 199 cells/µl.

NigeriaVIH/sidapublished 2024Annals of African medicinePubMeddocument of 12 observations

32 %The prevalence of metabolic syndrome (MS) among HIV patients on antiretroviral therapy (ART) was 32.0% according to NCEP-ATP III criteria.

Nigeriasyndrome métabolique · VIH/sidapublished 2022African health sciencesPubMeddocument of 6 observations

1.45 AOREver use of psychoactive substance was associated with increased CD4 count among HIV-positive clients (adjusted odds ratio 1.45; 95% CI 1.22–1.83).

NigeriaVIH/sidapublished 2022West African journal of medicinePubMeddocument of 7 observations

19 %Of 1355 respondents with available HIV genotypes, 293 (19%) had evidence of drug-resistant mutations that conferred resistance to at least one antiretroviral drug.

NigeriaVIH/sidaobserved 2018published 2023AIDS (London, England)PubMeddocument of 3 observations

98.2 %On-schedule refill appointments for HIV treatment improved to 98.2% post-transition.

NigeriaVIH/sidapublished 2025BMC health services researchPubMeddocument of 9 observations

17.6 %Subclinical hypothyroidism was the most common type of thyroid dysfunction in HAART-naïve HIV sero-positive patients, with a prevalence of 17.6%.

Nigeriasubclinical hypothyroidism · VIH/sidapublished 2021West African journal of medicinePubMeddocument of 6 observations

117.8 stigma_scoreThose who had been on HIV treatment for >3 years had a mean HIV-related stigma score of 117.8 ± 15.2 compared to 110.3 ± 20.1 for those who had been on treatment for <2 years.

NigeriaVIH/sidaobserved between July 2023 and April 2024published 2025Frontiers in public healthPubMeddocument of 5 observations

33.3 %One-third of new HIV infections occur among young people living with HIV.

NigeriaVIH/sidapublished 2022The Pan African medical journalPubMeddocument of 12 observations

3 per_index_clientThe elicitation ratio for the elicitation box model was 1:3.

NigeriaVIH/sidaobserved Between March 2021 and April 2022published 2024Global health, science and practicePubMeddocument of 8 observations

33,500,000 USDAt current coverage rates, the annual treatment costs for children living with HIV in Nigeria range from US$ 33.5 million in 2020 to US$ 32 million in 2025.

NigeriaVIH/sidaobserved 2020 to 2025published 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations

0.36 AORThe adjusted odds ratio of sub-optimal adherence was 0.36 for people living with HIV on ART for duration ≥ 24 months compared to those on ART for less than 24 months.

NigeriaVIH/sidapublished 2023West African journal of medicinePubMeddocument of 5 observations

0.218 kappaThere was mild agreement (kappa: 0.218) between tuberculin skin test and QuantiFERON-TB Gold In-Tube assay in the diagnosis of latent tuberculosis infection among patients with HIV infection.

Nigerialatent tuberculosis infection · VIH/sidapublished 2021The Pan African medical journalPubMeddocument of 5 observations

3.7 %A selection rate of 3.7% (1 out of 27) of resistance mutations was observed in drug-naive HIV-HBV-coinfected patients in southwestern Nigeria.

Nigeriahépatite B · VIH/sidapublished 2019Antiviral therapyPubMeddocument of 4 observations

17.3 %Among 415 people living with HIV attending a tertiary care center in Kano, Nigeria, 17.3% cited remote access to specialist care as a primary motivation for teleconsultation acceptance.

NigeriaVIH/sidapublished 2025Telemedicine journal and e-health : the official journal of the American Telemedicine AssoPubMeddocument of 6 observations

98.8 %HIV-1 accounted for 98.8% of confirmed HIV-positive cases in the Nigeria AIDS Indicator and Impact Survey (NAIIS) 2018.

NigeriaVIH/sidaobserved 2018published 2022PLOS global public healtheurope_pmcdocument of 10 observations

83.4 %83.4% of children living with HIV were diagnosed during the implementation period.

NigeriaVIH/sidapublished 2023BMC pediatricsPubMeddocument of 10 observations

23.3 %23.3% of respondents reported acquiring HIV/AIDS through unprotected sex.

NigeriaVIH/sidapublished 2026AIDS carePubMeddocument of 7 observations

1,266,512 patient_recordsBy June 30, 2021, 1,266,512 patient records in the National Data Repository had fingerprint template data to support unique patient identification.

NigeriaVIH/sidaobserved June 30, 2021published 2023Methods of information in medicinePubMeddocument of 5 observations

200 copies/mLViral non-suppression was defined as viral load ≥ 200 copies/mL.

NigeriaVIH/sidapublished 2025AIDS and behaviorPubMeddocument of 2 observations

50 %Fewer than half of facilities reported achieving rates of ≥90% completion of family trees for index testing in children.

NigeriaVIH/sidapublished 2025Journal of the International Association of Providers of AIDS CarePubMeddocument of 3 observations

505 clientsOf the 7483 clients tracked, 505 (6.7%) could not be reached by phone or located at their addresses.

NigeriaVIH/sidapublished 2019AIDS research and therapyPubMeddocument of 14 observations

24.8 %Between July 2016 and October 2017, 24.8% of male participants at Baby Shower events in Benue State, Nigeria reported they had never been tested for HIV.

NigeriaVIH/sidaobserved July 2016 to October 2017published 2021PloS onePubMeddocument of 11 observations

100 %In health facilities in Benue State, Nigeria during a similar time period, 100% of HIV-positive pregnant women were linked to antiretroviral therapy.

NigeriaVIH/sidaobserved similar time periodpublished 2021PloS onePubMeddocument of 11 observations

98.26 %Of newly identified HIV-positive individuals during the surge, 98.26% (100,393/102,165) were linked to antiretroviral therapy in Akwa Ibom State, Nigeria.

NigeriaVIH/sidapublished 2022PloS onePubMeddocument of 7 observations

3.4 %Among the 344 women living with HIV, 12 (3.4%) were peri-menopausal.

NigeriaVIH/sidapublished 2025West African journal of medicinePubMeddocument of 10 observations